CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.516
EU - Europa 7.128
AS - Asia 1.306
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 7
SA - Sud America 6
OC - Oceania 3
Totale 17.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.484
IT - Italia 1.983
SE - Svezia 1.600
IE - Irlanda 1.247
UA - Ucraina 601
DE - Germania 595
CN - Cina 543
TR - Turchia 531
GB - Regno Unito 348
FI - Finlandia 212
RU - Federazione Russa 149
CH - Svizzera 128
AT - Austria 85
SG - Singapore 81
IL - Israele 54
BE - Belgio 49
EU - Europa 47
VN - Vietnam 39
CA - Canada 32
FR - Francia 32
AL - Albania 22
JP - Giappone 17
NL - Olanda 15
KR - Corea 10
IN - India 8
DK - Danimarca 7
ES - Italia 7
HU - Ungheria 6
PL - Polonia 6
RS - Serbia 6
CZ - Repubblica Ceca 5
BG - Bulgaria 4
LU - Lussemburgo 4
EG - Egitto 3
IR - Iran 3
PT - Portogallo 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BR - Brasile 2
CL - Cile 2
GR - Grecia 2
HK - Hong Kong 2
IM - Isola di Man 2
LI - Liechtenstein 2
MD - Moldavia 2
MT - Malta 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
TW - Taiwan 2
ZA - Sudafrica 2
AR - Argentina 1
BN - Brunei Darussalam 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 17.015
Salva come PNG Salva come JPEG
Città #
Chandler 1.373
Pisa 1.303
Jacksonville 1.300
Dublin 1.245
Izmir 529
Wilmington 526
Ashburn 504
Ann Arbor 399
Boston 280
Boardman 278
Millbury 264
Düsseldorf 220
Mestre 188
San Mateo 181
New York 156
Ogden 121
Bremen 119
Seattle 109
Bern 107
Princeton 106
Washington 93
Lawrence 91
Woodbridge 88
Vienna 79
Beijing 78
San Paolo di Civitate 67
Saint Petersburg 63
Dearborn 53
Singapore 52
Holon 51
Milan 50
Guangzhou 47
Brussels 45
Shanghai 40
Dong Ket 39
Helsinki 38
Scuola 38
Wuhan 31
San Giuliano Terme 28
Fairfield 26
Rome 26
Hefei 24
Norwalk 23
Toronto 22
Chicago 21
Nanjing 21
Houston 19
Las Vegas 19
Bientina 16
Edinburgh 15
Andover 14
Jiaxing 14
Kunming 14
Los Angeles 14
Tokyo 14
Berlin 13
Padova 12
Shenzhen 12
San Diego 11
Cambridge 10
Lausanne 10
Wuxi 10
Falls Church 9
Ferrara 9
Jinan 9
Paris 9
Zurich 9
Florence 8
London 8
Tappahannock 8
Voghera 8
Auburn Hills 7
Seoul 7
Stockholm 7
Verona 7
Yiwu 7
Budapest 6
Cusano Milanino 6
Graz 6
Nanchang 6
Trieste 6
Amsterdam 5
Centrale 5
Livorno 5
Redmond 5
Shenyang 5
Tiantai Chengguanzhen 5
Chantilly 4
Chengdu 4
Council Bluffs 4
Fuzhou 4
Genoa 4
Hangzhou 4
Hanover 4
Lappeenranta 4
Leawood 4
Luxembourg 4
Prague 4
Quanzhou 4
Shaoxing 4
Totale 10.983
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 1.122
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 159
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 156
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 142
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 140
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 136
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 132
null 129
NGF steers microglia toward a neuroprotective phenotype 127
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 126
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 126
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 124
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 120
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 120
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 116
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 116
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 115
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 114
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 114
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 112
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 112
The role of Nerve Growth Factor in development and in ALzheimer's disease 110
Nerve Growth Factor regulates astrocyte physiology in vivo 110
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 109
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 109
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 109
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 108
Morphological basis for pineal secretion in domestic Ungulata 108
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 105
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 105
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 104
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 104
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 104
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 104
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 102
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 102
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 102
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 101
Involvement of NGF in early stages of chick embryo development 101
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 101
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 101
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 101
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 100
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 100
A new generation of NGF-based therapy for Alzheimer’s disease 100
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 99
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 99
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 99
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 97
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 96
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 96
Expression of the melatonin receptors in Xenopus laevis 96
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 95
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 95
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 95
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 95
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 94
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 94
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 93
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 93
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 93
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 93
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 92
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 92
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 92
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 92
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 91
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 91
Interfering with the intracellular trafficking of Aß Oligomers with conformational intrabodies 91
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 91
Memoquin, a novel multifunctional compound for Alzheimer’s disease: an up-date on preclinical studies 90
Transgenic mouse models of neurotrophin function and effects on amyloid plaques and neurofibrillary pathology 90
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 90
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 89
Development of human Nerve Growth Factor muteins with reduced algesic properties 89
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 89
Design and characterization of human Nerve Growth Factor muteins with reduced algesic properties and their application to drug discovery in Alzheimer’s disease 88
Rage deficiency rescues Aß-mediated inhibitory effects of different forms of long-term potentiation in mouse neocortex 88
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 88
Phenotypic characterization of mice expressing anti-TrkA antibodies 88
Memoquin, a new compound to attack Alzheimer's disease: preclinical studies 87
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 87
Rat visual cortical neurones express TrkA NGF receptor 86
Melatonin receptors in brain and peripheral arteries 86
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 86
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 85
A small molecule targeting the multifactorial nature of Alzheimer's disease 85
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 84
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 84
Non-human transgenic animals for the study of neurodegenerative syndromes 84
Effects of combination treatment of galantamine and memantine on AD11 anti-NGF mice 84
Synaptic plasticity impairment in visual cortex of adult anti-NGF mice 84
Organotypic cultures from AD11 anti-NGF transgenic mice: an in vitro model system to study neurodegeneration 84
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 84
The effects of knocking out of p75NTR on the neurodegenerative phenotype in AD11 anti-NGF mice 84
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 84
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 83
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 83
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 83
Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice 83
Totale 11.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.473 246 169 24 13 186 52 300 53 191 32 195 12
2020/20212.437 195 17 501 16 185 216 76 197 209 421 128 276
2021/20221.470 141 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.921 268 47 215 47 137 388 72 106 209 72 10 350
2024/20251.243 1.243 0 0 0 0 0 0 0 0 0 0 0
Totale 17.287